CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on identifying and validating new therapeutic targets for preventing and treating coronary artery disease and stroke by exploring genomic variants linked to atherosclerosis. It combines academic and small to medium-sized enterprise expertise to investigate molecular mechanisms and develop high-throu…
Atherosclerosis and its most disabling sequelae, coronary artery disease (CAD) and stroke, are leading causes of death in Europe.
Until now, preventive and therapeutic interventions for these diseases aim at ameliorating the effects of established cardiovascular risk factors.
More recently, results of genome-wide association (GWA) studies added to our perception of mechanisms leading to atherosclerosis.
At present, over 40 CAD and several genomic risk loci have been identified, the majority thro…
DEUTSCHES HERZZENTRUM MUNCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Leicester
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Lubeck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
